Athletic Performance and Testosterone in Women: Optimizing Strength and Recovery

By The Project Rx Medical Team

The Performance Hormone Women Overlook

Walk into most training facilities and you'll hear endless conversation about protein timing, sleep hygiene, periodization strategies. Mention testosterone and the room goes quiet—or assumes you're speaking about male athletes. Yet testosterone is as foundational for female athletic performance as it is for male, governing muscle protein synthesis, recovery capacity, and the body's ability to adapt to progressive training stress.

Many active women train through symptoms of testosterone deficiency without recognizing them. Stalled strength progression becomes attributed to programming errors. Persistent fatigue gets blamed on insufficient sleep. Difficulty building muscle is chalked up to genetics. Meanwhile, the hormonal foundation required for these adaptations has quietly eroded.

Testosterone in women occupies an uncomfortable middle ground in sports medicine—acknowledged as physiologically important, yet rarely discussed as a legitimate target for optimization. This leaves performance-minded women navigating a landscape with little guidance, often suffering symptoms that masquerade convincingly as training issues.

The Project Rx offers physician-guided hormonal optimization grounded in precision medicine, comprehensive lab evaluation, and ongoing clinical monitoring. This is not performance enhancement in the prohibited sense, but rather the restoration and optimization of endogenous hormonal function under legitimate medical supervision for women whose levels have declined to the point of affecting health and performance. Not everyone qualifies—eligibility is determined by licensed providers based on individual medical evaluation, lab work, and clinical presentation.

Testosterone in Women: Levels, Function, and the Athletic Window

The clinical reference range for total testosterone in women typically spans 15–70 ng/dL, though some laboratories report slightly different parameters. This represents a remarkably wide range—nearly fivefold variation between the low and high ends of "normal." For context, premenopausal women generally maintain higher testosterone in women levels than postmenopausal women, whose testosterone production declines alongside estrogen after ovarian function ceases.

The challenge for athletic women is that clinical "normal" encompasses a vast physiological territory. A woman with total testosterone of 20 ng/dL and one with 65 ng/dL are both technically within range, yet their anabolic capacity, recovery profiles, and training adaptation potential differ substantially. Research published in the Journal of Clinical Endocrinology & Metabolism has demonstrated that even within normal ranges, testosterone in women levels correlate with lean body mass, bone mineral density, and physical function.

Testosterone's role in female physiology extends far beyond reproduction:

Muscle protein synthesis: Testosterone activates androgen receptors in skeletal muscle, initiating the signaling cascades that drive protein accretion and muscle growth
Satellite cell activation: These muscle stem cells, essential for repair and hypertrophy, are modulated by androgens
Bone density: Testosterone stimulates osteoblast activity and helps maintain skeletal strength under mechanical loading
Red blood cell production: Erythropoiesis is androgen-dependent, affecting oxygen-carrying capacity
Recovery capacity: Mitochondrial biogenesis and tissue repair processes are influenced by testosterone signaling
Motivation and competitive drive: Central nervous system effects include mood, assertiveness, and training motivation

Women produce testosterone primarily in the ovaries and adrenal glands, with smaller amounts synthesized peripherally from precursor hormones. Total production is roughly one-tenth that of men, but the biological importance is no less significant. Androgen receptors are widely distributed throughout female tissues, and research in Medicine & Science in Sports & Exercise has confirmed their critical role in training adaptation.

As women age, testosterone in women levels decline—precipitously after menopause, but gradually beginning in the third and fourth decades even in premenopausal women. Active women may notice performance decline years before experiencing classic clinical symptoms. The athlete who could once recover between heavy training sessions now requires extra days. Strength progression that once came reliably now stalls despite meticulous programming.

The concept of "optimal" testosterone in women levels for athletic performance cannot be reduced to a single number. Individual variation in androgen receptor sensitivity, sex hormone-binding globulin (SHBG) levels, and tissue responsiveness means that clinical evaluation and physician oversight are essential. What constitutes optimization for one woman may be insufficient or excessive for another.

How Low Testosterone Affects Strength, Power, and Recovery

Generic discussions of low testosterone in women often center on libido, energy, and mood—all legitimate concerns, but they miss the performance-specific manifestations that active women experience first. The athlete with declining testosterone doesn't necessarily feel depressed or uninterested in sex. She feels like her training has stopped working.

Performance-specific presentations include:

Impaired recovery between sessions: The 48-hour window that once allowed full recuperation now stretches to 72 or 96 hours. Muscle soreness persists longer. The nervous system feels inadequately restored. Training frequency must be reduced to avoid accumulating fatigue.

Stalled strength progression despite consistent programming: Progressive overload requires the body to adapt by building contractile tissue and neural efficiency. When testosterone in women levels fall below the threshold required for anabolic signaling, adaptation stalls. The weight that should have increased by five pounds this month remains stubbornly immovable.

Difficulty building or maintaining muscle mass: Even in caloric surplus with adequate protein, muscle accretion becomes frustratingly slow. In some cases, lean mass declines despite continued resistance training. Body composition shifts unfavorably despite unchanged nutrition.

Decreased training motivation and competitive drive: This is not clinical depression, but rather a dulling of the edge that makes an athlete eager to train. Sessions feel obligatory rather than compelling. The competitive fire that once burned reliably now flickers.

Prolonged injury recovery: Soft tissue healing, which depends on protein synthesis and cellular repair mechanisms, becomes slower. The minor strain that should resolve in two weeks lingers for four. Chronic issues that should respond to appropriate rehabilitation remain stubbornly persistent.

Persistent fatigue despite adequate sleep and nutrition: This is the most insidious symptom, as it can be attributed to countless factors. When sleep is optimized, nutrition is adequate, and training volume is reasonable, yet fatigue persists, hormonal factors warrant investigation.

The mechanisms connecting these symptoms to testosterone are well-established in research. Muscle protein synthesis is directly stimulated by androgen receptor activation in skeletal muscle fibers. Studies using stable isotope methodology have demonstrated that testosterone administration increases the fractional synthesis rate of muscle proteins in women.

Satellite cells—the resident stem cells of skeletal muscle—express androgen receptors and their proliferation and differentiation are modulated by testosterone. Without adequate androgenic signaling, the muscle's capacity to repair microtrauma and add new myonuclei is compromised. Research published in the American Journal of Physiology has documented that androgen receptor blockade impairs satellite cell function and blunts hypertrophic response to resistance training.

Mitochondrial biogenesis, the process by which cells increase their energetic capacity, is influenced by testosterone through multiple pathways including PGC-1α upregulation. Lower testosterone can mean reduced mitochondrial density and impaired oxidative capacity—translating to decreased endurance and slower recovery of energy systems.

The IGF-1 (insulin-like growth factor-1) axis interacts closely with testosterone in governing anabolic processes. Testosterone influences hepatic and local IGF-1 production, and the two hormones work synergistically to promote tissue growth and repair. Women with low testosterone often show correspondingly low IGF-1, compounding the anabolic deficit.

Training Hard While Undertreated: Why Active Women Fall Through the Cracks

Female athletes and highly active women are systematically underdiagnosed when it comes to testosterone deficiency. Several factors contribute to this clinical blind spot.

Symptom misattribution is perhaps the most common pitfall. When an active woman presents with persistent fatigue, declining performance, and difficulty recovering, the default assumption is often overtraining syndrome or relative energy deficiency in sport (RED-S). While these are legitimate concerns that must be ruled out, the symptom overlap with hormonal deficiency means that testosterone is rarely tested unless other diagnoses are excluded first.

Provider awareness gaps compound the problem. Sports medicine training has historically focused on menstrual function, iron status, and bone health in female athletes, with testosterone receiving minimal attention. Many clinicians are unaware that testosterone plays a significant role in female athletic performance, or they harbor misconceptions about appropriate testing and treatment.

Limited discussion in female sports medicine literature means that even conscientious providers may not have access to evidence-based protocols. While the research on testosterone and muscle protein synthesis in women is robust, it rarely appears in sports medicine continuing education or practice guidelines focused on female athletes.

Hesitancy to test or treat stems partly from outdated concerns about virilization and partly from the complexity of interpreting female testosterone levels. The wide reference range, the need to account for SHBG and free testosterone, and the absence of clear consensus guidelines make some providers uncomfortable pursuing this avenue.

The result is that active women often spend months or years attributing hormonal symptoms to training errors, nutrition inadequacies, or psychological factors. Strength coaches adjust programming. Dietitians manipulate macronutrients. Sleep is optimized. Stress management is implemented. Yet the underlying hormonal deficiency remains unaddressed.

To be clear, training variables and lifestyle factors must be optimized—these are foundational. The athlete in chronic caloric deficit or the woman sleeping four hours per night will not benefit from testosterone optimization until those fundamental issues are resolved. But once nutrition, sleep, stress, and programming are genuinely adequate, and performance symptoms persist alongside suggestive lab findings, physician-guided hormonal evaluation becomes appropriate.

Women produce testosterone through two primary pathways: ovarian synthesis (which declines after menopause) and adrenal production (via DHEA and DHEA-S conversion). Testosterone in women levels can decline due to natural aging, surgical menopause, primary ovarian insufficiency, adrenal insufficiency, chronic illness, certain medications (particularly oral contraceptives and corticosteroids), and other endocrine disorders.

Distinguishing true hormonal deficiency from training-related or nutritional issues requires clinical expertise and comprehensive evaluation. This is precisely why physician-guided assessment is not optional but essential—and why not everyone who seeks testosterone optimization will qualify for treatment. Licensed providers must determine, based on symptoms, lab work, medical history, and clinical judgment, whether hormonal intervention is medically appropriate.

Precision Testing: What Active Women Need to Know

Testosterone is a Schedule III controlled substance under federal law, and its prescription requires documented medical justification including appropriate laboratory testing. For active women seeking performance optimization through hormonal health, understanding what should be tested—and how to interpret results—is foundational.

Comprehensive hormonal assessment for athletic women should include:

Total testosterone: The sum of all testosterone in circulation, both bound and unbound. This is the standard screening test and provides the broadest picture of androgen status. Reference ranges typically fall between 15–70 ng/dL for women, though individual laboratories may vary slightly.

Free testosterone: The biologically active fraction not bound to SHBG or albumin, typically representing 1–2% of total testosterone. Free testosterone is often a more accurate indicator of androgenic activity than total testosterone, particularly in women with altered SHBG levels.

Sex hormone-binding globulin (SHBG): This carrier protein binds testosterone with high affinity, rendering it biologically unavailable. SHBG is increased by estrogen, thyroid hormone, and aging, and decreased by insulin resistance, androgens, and obesity. A woman with high SHBG may have normal total testosterone but low free testosterone—and corresponding symptoms.

DHEA-S (dehydroepiandrosterone sulfate): A precursor hormone produced by the adrenal glands that can be converted to testosterone peripherally. DHEA-S levels help assess adrenal androgen production and can identify adrenal insufficiency.

Estradiol: The primary estrogen in women, essential for bone health, cardiovascular function, and mood. Estrogen and testosterone interact extensively, and understanding the balance is critical for safe, effective hormone optimization.

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH): These pituitary hormones help determine whether low testosterone is primary (ovarian or adrenal) or secondary (pituitary). Elevated LH and FSH with low testosterone suggest ovarian insufficiency or menopause.

Additional testing may include thyroid function (TSH, free T3, free T4), prolactin, cortisol, metabolic markers, and other hormones depending on clinical presentation.

Timing and methodology matter considerably. Testosterone in women levels exhibit diurnal variation, peaking in the early morning and declining throughout the day. For this reason, testing is typically performed in the morning, ideally between 7:00 and 10:00 AM. In premenopausal women, cycle timing can affect results—testing is often performed in the follicular phase (days 3–5 of the cycle) for consistency, though some providers prefer mid-cycle or luteal phase testing depending on clinical context.

Fasting vs. non-fasting status can affect certain hormones and should be standardized. DHEA-S and testosterone are not significantly affected by recent food intake, but other metabolic markers may be, so many providers request fasting samples for consistency.

Laboratory technique is also critical. Testosterone assays designed for male ranges (typically 300–1000 ng/dL) often lack the sensitivity and precision required to accurately measure female levels, which are tenfold lower. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is considered the gold standard for measuring testosterone in women, offering superior accuracy compared to older immunoassay methods.

Interpretation requires clinical expertise. A woman with total testosterone of 25 ng/dL and high SHBG may have very low free testosterone and corresponding symptoms. Another woman with the same total testosterone but normal SHBG may be asymptomatic. Context—including age, menstrual status, symptoms, body composition, training history, and concurrent medical conditions—is essential for determining whether hormonal intervention is appropriate.

Because testosterone is a controlled substance, providers must document medical necessity through both symptomatic presentation and laboratory confirmation of deficiency. Eligibility for treatment is determined by licensed medical professionals based on individual evaluation—not everyone who seeks optimization will qualify, and those who do will require ongoing monitoring and prescription oversight. For a deeper exploration of laboratory evaluation, testosterone testing for women covers the nuances of ordering and interpreting these panels.

Optimizing Testosterone for Athletic Performance: Evidence and Protocols

The evidence base for testosterone therapy in women has expanded considerably over the past two decades, though much of the research has focused on sexual function, bone density, and quality of life rather than athletic performance specifically. Still, the mechanisms by which testosterone improves muscle mass, strength, and recovery in women are well-characterized.

Randomized controlled trials in postmenopausal women have consistently demonstrated that testosterone supplementation increases lean body mass and reduces fat mass. A landmark study published in the Journal of Clinical Endocrinology & Metabolism found that postmenopausal women receiving transdermal testosterone showed significant improvements in appendicular lean mass and grip strength compared to placebo. The effects were dose-dependent and required several months to manifest fully.

Research on bone mineral density has shown that testosterone therapy helps preserve or improve bone strength in women, particularly when combined with estrogen. This is relevant not only for fracture prevention but also for athletes whose skeletal system must withstand high mechanical loads during training. Studies in the Journal of Bone and Mineral Research have documented improvements in both trabecular and cortical bone with testosterone treatment.

Muscle protein synthesis studies using stable isotope methodology have demonstrated that testosterone administration increases the fractional synthesis rate of muscle proteins in women. This translates to improved capacity for muscle repair and growth in response to resistance training stimulus.

Recovery and well-being outcomes extend beyond purely physical measures. Multiple trials have reported improvements in energy, vitality, and mood with testosterone therapy in women with documented deficiency. For athletes, this translates to improved training motivation, competitive drive, and capacity to sustain high training volumes.

The relationship between testosterone in women levels and mood is well-documented, and women experiencing both performance decline and mood symptoms may find that hormonal optimization addresses multiple concerns simultaneously. Depression and low testosterone in women explores this connection in depth.

Delivery methods for testosterone in women include:

Topical preparations (creams, gels): Allow for flexible dosing, easy adjustment, and steady-state levels when applied daily. Compounded formulations can be titrated precisely to achieve target levels. Compounded medications are not reviewed by the FDA for safety or efficacy, but represent clinically appropriate alternatives when individualized dosing is required.

Injectable testosterone: Typically cypionate or enanthate esters, administered weekly or biweekly. Injectables provide reliable absorption and avoid first-pass metabolism, though they may produce more variation in levels between doses.

Testosterone pellets: Subcutaneously implanted pellets that release testosterone over several months. Pellets offer convenience and stable levels but less flexibility for dose adjustment.

The choice among delivery methods depends on individual preferences, lifestyle factors, response to treatment, and clinical considerations. Testosterone cream vs. pellets for women provides a detailed comparison of these modalities.

The Project Rx offers physician-guided, personalized testosterone optimization protocols as part of comprehensive women's hormonal health programs. Treatment plans are individualized based on lab results, symptoms, medical history, and treatment goals. Compounded medications offered through The Project Rx are not FDA-approved—compounded medications are not reviewed by the FDA for safety or efficacy—but serve as alternatives when clinically appropriate for patients requiring customized dosing or formulations.

Response to treatment varies considerably among individuals. Some women notice improvements in recovery and training capacity within weeks, while others require several months to experience full benefits. Strength gains, muscle mass increases, and performance enhancements cannot be guaranteed and depend on numerous factors including baseline hormone levels, training stimulus, nutrition, genetics, and treatment adherence. Treatment outcomes vary by individual.

Potential side effects exist with any hormonal therapy. These may include acne, increased facial or body hair growth, scalp hair thinning, voice changes, clitoral enlargement, mood changes, and lipid alterations. The risk and severity of side effects are dose-dependent and vary by individual. Prescription decisions are made solely by licensed medical professionals after thorough evaluation of risks and benefits.

Testosterone therapy in women is not about achieving supraphysiologic levels or pharmaceutical enhancement. It is about restoring endogenous function to a range that supports health, vitality, and the capacity to adapt to training—under continuous medical supervision with regular monitoring.

Supporting Hormonal Health: Training, Nutrition, and Recovery Strategies

Physician-guided hormonal optimization exists within a broader context of lifestyle factors that profoundly influence endogenous testosterone production. For active women, addressing these fundamentals is not optional—it is prerequisite to any discussion of medical intervention.

Adequate caloric intake is perhaps the most critical factor. Chronic energy deficiency, whether intentional or unintentional, suppresses the hypothalamic-pituitary-gonadal axis and reduces testosterone production. Research on Relative Energy Deficiency in Sport (RED-S) has documented that low energy availability—defined as insufficient caloric intake relative to exercise expenditure—disrupts multiple hormonal systems including reproductive hormones, thyroid function, and metabolic regulation.

For women seeking to optimize testosterone in women levels, chronic underfueling is incompatible with that goal. Energy availability should be sufficient to support training demands, maintain menstrual function (in premenopausal women), and preserve lean mass. This typically requires at least 45 kcal per kilogram of fat-free mass per day, though individual needs vary based on training volume and metabolic factors.

Resistance training and progressive overload stimulate endogenous testosterone production through acute post-exercise elevations and chronic adaptations. Heavy compound movements—squats, deadlifts, presses—produce greater hormonal response than isolation exercises. Training volume, intensity, and frequency should be optimized for the individual, with adequate recovery between sessions.

Paradoxically, excessive training volume without adequate recovery can suppress testosterone through chronic elevation of cortisol and other stress hormones. The goal is not maximal training stress, but optimal training stress—the amount that stimulates adaptation without overwhelming recovery capacity.

Sleep quality and duration regulate hormonal secretion across multiple systems. Testosterone production occurs primarily during sleep, and chronic sleep restriction or poor sleep quality reduces testosterone in women levels in both men and women. Studies have shown that even modest sleep deprivation—five hours per night instead of eight—can reduce testosterone by 10–15% within a week.

Active women should prioritize seven to nine hours of quality sleep per night, with attention to sleep hygiene: consistent sleep-wake timing, dark and cool sleeping environment, minimizing blue light exposure in the evening, and managing stress that may interfere with sleep onset or maintenance.

Stress management addresses the inverse relationship between cortisol and testosterone. Chronic psychological or physiological stress elevates cortisol, which inhibits gonadotropin-releasing hormone (GnRH) and subsequently reduces LH, FSH, and testosterone production. For athletes, stress includes not only psychological stressors (work, relationships, financial concerns) but also training stress, inflammation, and metabolic stress.

Effective stress management strategies include meditation, breathwork, time in nature, social connection, and appropriate periodization of training to include recovery phases. For women juggling high training volume with professional and personal demands, stress management is not luxury—it is performance necessity.

Micronutrient status influences testosterone production through several pathways. Zinc is required for androgen receptor function and steroidogenesis. Vitamin D acts as a hormone precursor and has been associated with testosterone in women levels in multiple studies. Magnesium is involved in hundreds of enzymatic reactions including those related to steroid hormone synthesis.

Deficiencies in these nutrients are common among athletes due to increased losses through sweat, high metabolic turnover, and sometimes inadequate intake. Testing for and correcting deficiencies—through diet or supplementation when appropriate—supports endogenous hormone production.

Body composition affects testosterone through multiple mechanisms. Very low body fat—common in aesthetic sports or endurance athletes—reduces aromatization of androgens to estrogens and can suppress the HPG axis. Conversely, excessive adiposity increases aromatase activity and SHBG production, which can reduce free testosterone despite normal or elevated total testosterone.

The optimal body composition for hormonal health and athletic performance varies by individual and sport, but extremes in either direction typically prove counterproductive.

These lifestyle factors are complementary to—not replacements for—medical treatment when true hormonal deficiency exists. A woman with primary ovarian insufficiency or bilateral oophorectomy will not restore testosterone to functional levels through sleep optimization alone. But a woman with borderline testosterone whose nutrition, sleep, and stress management are chaotic may be able to improve levels substantially through lifestyle intervention, potentially avoiding or delaying the need for medical treatment.

Physician-guided evaluation helps distinguish between these scenarios and determines the appropriate course of action for each individual. For those who do qualify for medical intervention, optimizing these lifestyle factors enhances treatment response and overall outcomes.

Monitoring Progress: Performance Metrics and Hormonal Markers

Testosterone optimization for athletic performance is not a "set it and forget it" intervention. Effective treatment requires ongoing monitoring of both laboratory markers and functional outcomes, with protocol adjustments based on individual response.

Laboratory monitoring includes regular follow-up testing to ensure testosterone in women levels are within the target range. For most women on testosterone therapy, follow-up labs are performed 4–6 weeks after initiating treatment or changing dose, then every 3–6 months once stable. Testing includes total testosterone, free testosterone (or calculated free testosterone based on total testosterone and SHBG), SHBG, and hormone panels as clinically indicated.

The goal is not to maximize testosterone to the upper limit of the reference range, but rather to achieve levels that resolve symptoms and support performance while minimizing side effects. For some women, this may occur at total testosterone of 40 ng/dL; for others, 60 ng/dL or higher may be required. Individual variation in androgen receptor sensitivity and tissue responsiveness means that optimal levels are determined empirically through careful titration and monitoring.

Additional monitoring includes metabolic markers (lipid panel, glucose, hemoglobin A1c), liver function tests, complete blood count (to monitor for erythrocytosis), and other parameters as clinically appropriate. Hormonal therapies can affect multiple physiological systems, and comprehensive monitoring helps detect and address any adverse effects early.

Performance metrics provide functional validation of hormonal optimization. Unlike laboratory values, which change relatively quickly, performance adaptations may require weeks or months to manifest fully. Relevant metrics include:

Strength progression: Tracking key lifts (squat, deadlift, bench press, overhead press) with attention to both absolute strength and rate of progression. The athlete who was stalled at a particular weight for months should see gradual improvement if hormonal optimization is effective.

Recovery markers: Subjective measures such as muscle soreness duration, perceived readiness to train, sleep quality, and training motivation. More objective measures might include heart rate variability (HRV), resting heart rate, or grip strength as a proxy for neuromuscular recovery.

Body composition: Changes in lean mass and fat mass, measured through DEXA scan, bioelectrical impedance, or other validated methods. Testosterone optimization typically increases lean mass and reduces fat mass, though changes may be gradual and require several months to become apparent.

Training volume tolerance: The ability to sustain higher training frequency, volume, or intensity without excessive fatigue or injury. The woman who could only train heavy twice per week may find she can handle three or four sessions once hormonal status is optimized.

Injury recovery: For athletes dealing with chronic or recurrent soft tissue injuries, monitoring healing time and symptom resolution provides functional evidence of improved recovery capacity.

Symptom resolution tracking helps determine whether the intervention is addressing the presenting concerns. Standardized questionnaires or simple symptom checklists completed at regular intervals provide longitudinal data on fatigue, motivation, recovery, libido, mood, and other relevant domains.

Side effect monitoring is equally important. Any signs of virilization (voice deepening, clitoral enlargement, facial hair growth beyond mild peach fuzz), significant acne, mood changes, or other concerning symptoms warrant dose adjustment or discontinuation. The goal is optimization within physiologic ranges—not maximization at the cost of unacceptable side effects.

Protocol adjustments are made based on this comprehensive monitoring. If labs show testosterone in women levels remain low despite treatment, dose may be increased or delivery method changed. If levels are adequate but symptoms persist, other factors (thyroid function, cortisol, estrogen, vitamin D, iron status, sleep, nutrition) are investigated. If side effects occur, dose is reduced or formulation changed.

This is precision medicine in practice: individualized protocols, comprehensive monitoring, ongoing adjustment, and physician oversight throughout. It is the antithesis of one-size-fits-all approaches or protocols obtained without legitimate medical supervision.

Treatment requires ongoing prescription and medical oversight. Testosterone cannot be obtained legally without a prescription, and physicians who prescribe it bear responsibility for appropriate monitoring and patient safety. Women receiving testosterone therapy through The Project Rx benefit from concierge telehealth access to licensed providers who specialize in hormonal optimization and understand the unique considerations for active women.

This level of oversight is not bureaucratic inconvenience—it is medical necessity. Hormonal systems are complex, interdependent, and individual. What works beautifully for one woman may produce intolerable side effects in another. Determining the appropriate intervention, monitoring response, and adjusting protocols requires clinical expertise and cannot be self-directed.

Physician-Guided Optimization for the Ambitious Athlete

Testosterone is foundational for athletic performance in women—governing muscle protein synthesis, recovery capacity, bone density, and the physiological adaptations that make progressive training possible. Yet it remains curiously absent from most conversations about female athletic optimization, leaving countless women to train through symptoms of deficiency without recognizing the underlying cause.

The performance manifestations of low testosterone are subtle enough to be attributed to programming errors, inadequate nutrition, or simply aging. Strength progression stalls. Recovery between sessions lengthens. Muscle mass becomes difficult to build or maintain. Training motivation dulls. These symptoms are easily explained away—until comprehensive hormonal evaluation reveals that testosterone in women levels have quietly eroded.

For women with documented testosterone deficiency confirmed through appropriate laboratory testing and clinical evaluation, precision medicine offers evidence-based optimization under physician guidance. This is not enhancement through supraphysiologic dosing, but restoration of endogenous function to levels that support health, vitality, and athletic performance.

The Project Rx provides concierge telehealth access to licensed providers who specialize in hormonal health for active, health-conscious women. Treatment protocols are personalized based on comprehensive lab testing, medical history, symptoms, and individual goals. Monitoring is ongoing, with regular follow-up to ensure safety and efficacy. Adjustments are made based on both laboratory markers and functional outcomes.

Not everyone qualifies for testosterone therapy. Eligibility is determined by licensed medical professionals through individual evaluation that considers labs, symptoms, medical history, contraindications, and clinical judgment. Testosterone is a Schedule III controlled substance requiring medical justification and prescription oversight—it cannot be obtained without legitimate medical evaluation and ongoing care.

For women who do qualify, the intervention is offered not as isolated hormone replacement but as part of holistic optimization that includes nutrition guidance, training support, sleep and stress management, and comprehensive wellness protocols. The goal is maintaining the capacity to train hard, recover well, and build strength across decades, not merely months.

Compounded medications provided through The Project Rx are not FDA-approved—compounded medications are not reviewed by the FDA for safety or efficacy—but serve as clinically appropriate alternatives when individualized dosing or formulations are required. Potential side effects exist with any hormonal therapy, and prescription decisions are made solely by licensed medical professionals after thorough risk-benefit evaluation.

Treatment outcomes vary by individual. Specific performance improvements, timelines, or strength gains cannot be guaranteed. Response depends on baseline hormone levels, tissue sensitivity, training stimulus, nutrition, genetics, adherence, and numerous other factors.

For the ambitious athlete willing to pursue optimization through legitimate medical channels, the path begins with comprehensive evaluation. Women's testosterone treatment options provides an overview of the diagnostic and therapeutic process. An eligibility consultation with licensed providers can determine whether hormonal optimization is appropriate for your individual circumstances.

The conversation about testosterone and female athletic performance is long overdue. For too long, active women have been left to navigate performance decline without understanding the hormonal component—or told that symptoms are inevitable consequences of aging or training stress. Precision medicine offers a different narrative: that hormonal health is foundational to performance, that deficiency can be identified and addressed, and that optimization is possible under appropriate medical supervision.

This is not about shortcuts or pharmaceutical enhancement. It is about restoring the endogenous hormonal environment required for the body to adapt, recover, and build strength—the foundation upon which all training rests.

FAQ

What are normal testosterone in women levels, and what is optimal for athletic performance?

Normal testosterone in women levels typically range from 15–70 ng/dL for total testosterone, though reference ranges vary slightly among laboratories. This wide range means that "normal" encompasses significant physiological variation—a woman at 25 ng/dL and one at 60 ng/dL are both technically within range, yet their anabolic capacity differs substantially.

"Optimal" for athletic performance cannot be reduced to a single number. Individual variation in androgen receptor sensitivity, SHBG levels, and tissue responsiveness means that one woman may experience excellent performance outcomes at total testosterone of 45 ng/dL while another requires 65 ng/dL. Premenopausal women generally maintain higher levels than postmenopausal women, whose testosterone production declines after ovarian function ceases.

Determining optimal levels requires physician evaluation that considers symptoms, training response, body composition goals, and laboratory markers including free testosterone and SHBG—not just total testosterone. Treatment is titrated to the lowest effective dose that resolves symptoms and supports performance while minimizing side effects.

How can I tell if low testosterone is affecting my training and recovery?

Low testosterone in active women often presents as performance symptoms rather than classic clinical symptoms. Key indicators include:

Recovery between training sessions takes longer than it used to, requiring extra days for muscle soreness to resolve or for readiness to train to return
Strength progression has stalled despite consistent programming and progressive overload
Building or maintaining muscle mass has become difficult even with adequate protein and caloric intake
Training motivation and competitive drive have decreased—sessions feel obligatory rather than compelling
Injuries heal more slowly than expected, or chronic soft tissue issues persist despite appropriate rehabilitation
Persistent fatigue that is not explained by inadequate sleep, poor nutrition, or excessive training volume

If several of these symptoms persist despite optimizing training variables, nutrition, sleep, and stress management, hormonal evaluation through comprehensive lab testing is appropriate. Symptoms alone cannot diagnose testosterone deficiency—laboratory confirmation through testing of total testosterone, free testosterone, SHBG, and other relevant markers is required.

Because symptoms overlap considerably with overtraining, relative energy deficiency in sport (RED-S), thyroid dysfunction, and other conditions, physician evaluation is essential to distinguish hormonal deficiency from other causes of performance decline.

Is testosterone therapy safe for women who exercise regularly?

Testosterone therapy can be safe and effective for active women when prescribed appropriately, monitored carefully, and used at physiologic replacement doses rather than supraphysiologic enhancement doses. Key safety considerations include:

Appropriate patient selection: Women with documented testosterone deficiency confirmed through lab testing and symptomatic presentation are appropriate candidates. Those without deficiency should not receive testosterone.

Physiologic dosing: The goal is to restore levels to the mid-to-upper normal range for women, not to achieve male levels or supraphysiologic enhancement. Typical doses for women are approximately 1–10% of male replacement doses.

Regular monitoring: Follow-up lab testing every 3–6 months ensures levels remain in target range and allows detection of potential adverse effects on lipids, liver function, or blood counts.

Side effect awareness: Potential side effects include acne, increased body or facial hair, scalp hair thinning, voice changes, clitoral enlargement, mood changes, and lipid alterations. Risk is dose-dependent, and most side effects resolve with dose reduction or discontinuation.

Medical oversight: Testosterone is a Schedule III controlled substance requiring prescription and physician supervision. Treatment should never be self-directed or obtained without legitimate medical evaluation.

Individual variation: Some women tolerate testosterone therapy excellently; others experience side effects even at low doses. Response cannot be predicted in advance and requires empiric trial under medical supervision.

Prescription decisions are made solely by licensed medical professionals after thorough evaluation of individual risks, benefits, contraindications, and clinical appropriateness. Not everyone qualifies for treatment, and those who do require ongoing medical monitoring.

What's the difference between total testosterone and free testosterone for athletes?

Total testosterone measures all testosterone in the blood—both the portion bound to carrier proteins (primarily sex hormone-binding globulin or SHBG, and to a lesser extent albumin) and the small fraction that is unbound. Total testosterone provides a broad assessment of androgen status and is the standard screening test.

Free testosterone measures only the unbound, biologically active fraction—typically 1–2% of total testosterone in women. Free testosterone can diffuse into cells and bind to androgen receptors, initiating the signaling cascades that drive muscle protein synthesis, recovery, and other anabolic processes.

For active women, free testosterone is often more clinically relevant than total testosterone because SHBG can vary significantly based on factors including:

Estrogen levels (higher estrogen increases SHBG)
Thyroid function (hyperthyroidism increases SHBG)
Insulin resistance (insulin decreases SHBG)
Liver function
Age (SHBG tends to increase with aging)
Oral contraceptive use (markedly increases SHBG)

A woman with normal total testosterone but high SHBG may have low free testosterone and corresponding symptoms. Conversely, a woman with low-normal total testosterone but low SHBG may have normal free testosterone and be asymptomatic.

Free testosterone can be measured directly (though assays are often unreliable at female ranges) or calculated from total testosterone and SHBG using validated equations. Comprehensive hormonal assessment includes both total and free testosterone along with SHBG to provide complete clinical picture.

How long does it take to see performance improvements with testosterone optimization?

Timeline for performance improvements varies considerably among individuals and depends on baseline hormone levels, training stimulus, nutrition, genetics, and other factors. Treatment outcomes vary by individual, and specific timelines cannot be guaranteed.

That said, typical patterns observed in clinical practice and research include:

Subjective improvements in energy, recovery, and training motivation may appear within 2–4 weeks of achieving therapeutic testosterone in women levels. Women often report feeling more recovered between sessions and more motivated to train.

Strength gains typically require 6–12 weeks to become measurable, as neuromuscular adaptations and muscle protein accretion develop gradually. Some women notice faster progression on lifts that had previously stalled.

Muscle mass changes require even longer—typically 3–6 months or more—to become apparent through body composition testing. Muscle accretion is a slow process even under optimal hormonal conditions.

Performance capacity improvements such as ability to tolerate higher training volume or frequency may manifest gradually over weeks to months as recovery capacity improves.

Research in postmenopausal women has shown that lean mass improvements with testosterone therapy become statistically significant around 12 weeks and continue to accrue for 6–12 months or longer. Studies in athletic populations are limited, but mechanisms suggest similar timelines.

Importantly, hormonal optimization enhances the body's response to training—it does not replace the need for appropriate training stimulus, progressive overload, adequate nutrition, and recovery. Women who optimize testosterone but fail to train consistently or eat adequately will not see performance improvements. Those who combine hormonal optimization with excellent training and lifestyle practices typically see the best outcomes, though individual response varies.

Can lifestyle changes alone raise testosterone in women levels in active women?

For some women, lifestyle optimization can meaningfully improve testosterone in women levels without medical intervention. For others—particularly those with primary ovarian insufficiency, surgical menopause, or significant age-related decline—lifestyle changes alone will not restore levels to functional ranges.

Lifestyle factors that support endogenous testosterone production include:

Adequate caloric intake: Chronic energy deficiency suppresses the hypothalamic-pituitary-gonadal axis and reduces testosterone. Ensuring energy availability of at least 45 kcal/kg fat-free mass/day supports hormonal function.

Resistance training: Heavy compound exercises stimulate acute testosterone elevations and chronic upregulation of anabolic pathways. Optimal training volume and intensity with adequate recovery supports hormone production.

Sleep optimization: Seven to nine hours of quality sleep per night supports testosterone production, which occurs primarily during sleep. Even modest sleep restriction can reduce levels by 10–15%.

Stress management: Chronic elevation of cortisol inhibits GnRH and downstream testosterone production. Effective stress management supports hormonal balance.

Micronutrient adequacy: Zinc, vitamin D, and magnesium support steroidogenesis and androgen receptor function. Correcting deficiencies may improve endogenous production.

Body composition: Extremes of very low or very high body fat can suppress testosterone through different mechanisms. Maintaining moderate body fat supports hormonal health.

Women with borderline low testosterone whose lifestyle factors are suboptimal (chronic underfueling, excessive training stress, poor sleep, high psychological stress) may see meaningful improvements from addressing these fundamentals. Women with more significant deficiency—particularly postmenopausal women or those with ovarian insufficiency—will typically require medical intervention.

Physician evaluation helps determine whether lifestyle optimization alone is sufficient or whether medical treatment is appropriate. Even for women who do qualify for testosterone therapy, optimizing lifestyle factors enhances treatment response and overall outcomes.

What are the side effects of testosterone therapy for women?

Testosterone therapy in women can produce side effects, particularly at higher doses or in individuals who are particularly sensitive to androgens. Potential side effects include:

Androgenic effects: Acne, increased oily skin, increased body or facial hair growth (hirsutism), scalp hair thinning or male-pattern hair loss, voice deepening (potentially irreversible), clitoral enlargement. Risk is dose-dependent and most effects are reversible with dose reduction or discontinuation, though voice changes may persist.

Metabolic effects: Alterations in lipid profile (decreased HDL cholesterol, increased LDL cholesterol or triglycerides), insulin resistance, changes in body composition (increased lean mass, decreased fat mass).

Hematologic effects: Increased red blood cell production (erythrocytosis), which can increase blood viscosity and cardiovascular risk if excessive. Regular monitoring of hemoglobin and hematocrit is important.

Mood and behavioral effects: Increased assertiveness or aggression, mood changes, irritability. Some women experience improved mood and energy, while others may experience negative mood effects.

Liver effects: Oral testosterone (rarely used) can affect liver function. Injectable and transdermal forms have minimal hepatic impact but liver function is typically monitored as precaution.

Cardiovascular considerations: Effects on cardiovascular risk remain debated. Some studies suggest potential increases in cardiovascular events with testosterone therapy, while others show neutral or beneficial effects. Individual risk factors must be considered.

The goal of therapy is to use the lowest effective dose that resolves symptoms and supports performance while minimizing side effects. Most women tolerate physiologic testosterone replacement well when appropriately dosed and monitored. Those who experience significant side effects typically require dose adjustment or discontinuation.

Potential side effects exist with any hormonal therapy, and prescription decisions are made solely by licensed medical professionals after thorough evaluation of individual risks and benefits.

How is testosterone monitored during treatment for female athletes?

Comprehensive monitoring during testosterone therapy includes both laboratory testing and clinical assessment of symptoms and performance outcomes. Typical monitoring protocols include:

Laboratory monitoring:

Baseline labs before initiating treatment: total testosterone, free testosterone (or calculated free testosterone), SHBG, estradiol, LH, FSH, complete blood count, comprehensive metabolic panel, lipid panel, thyroid function, other hormones as indicated
Follow-up labs 4–6 weeks after starting therapy or changing dose to assess whether testosterone in women levels are in target range
Ongoing monitoring every 3–6 months once stable, including total testosterone, free testosterone, SHBG, CBC (to monitor for erythrocytosis), lipid panel, liver function tests, glucose/HbA1c
Additional testing as clinically indicated based on symptoms or side effects

Timing of lab draws: Morning collection (7–10 AM) for consistency due to diurnal variation. For premenopausal women, timing relative to menstrual cycle may be standardized. Trough levels (just before next dose) are often measured for injectable formulations to ensure levels remain adequate between doses.

Clinical monitoring:

Symptom tracking: energy, recovery, training motivation, strength progression, muscle mass, fatigue, mood, libido
Side effect assessment: acne, hirsutism, hair thinning, voice changes, mood changes, any concerning symptoms
Physical examination: blood pressure, weight, signs of virilization
Performance metrics: strength testing, body composition measurement, training volume tolerance, injury recovery

Protocol adjustments: Dose is adjusted based on combination of laboratory values and clinical response. If testosterone in women levels remain low despite treatment, dose may be increased or delivery method changed. If levels are adequate but symptoms persist, other factors are investigated. If side effects occur, dose is reduced or treatment discontinued.

Frequency of provider contact: Initial months often involve more frequent check-ins (every 4–6 weeks) to titrate dose and monitor response. Once stable, follow-up may extend to every 3–6 months, though women can contact providers between scheduled visits with questions or concerns.

This level of monitoring is not optional—it is required for safe, effective treatment. Testosterone is a controlled substance with potential side effects, and medical oversight ensures that therapy remains appropriate and beneficial. Women receiving testosterone therapy through The Project Rx have access to licensed providers who specialize in hormonal optimization and provide ongoing monitoring as part of personalized treatment protocols.